Analystreport

Aeglea BioTherapeutics, Inc. (NASDAQ: AGLE) had its price target lowered by analysts at Piper Sandler from $9.00 to $7.00.

Aeglea BioTherapeutics, Inc.  (AGLE) 
Last aeglea biotherapeutics, inc. earnings: 8/6 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.aegleabio.com/investor-overview